Literature DB >> 15834650

Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke.

Michael T Wunderlich1, Thorsten Hanhoff, Michael Goertler, Friedrich Spener, Jane F C Glatz, Claus-W Wallesch, Maurice M A L Pelsers.   

Abstract

This study aimed at an analysis of the release of Braintype and Heart-type Fatty Acid- Binding Proteins (B-FABP and HFABP) in acute ischaemic stroke and their potential value as neurobiochemical markers of brain damage. We investigated 42 consecutive patients admitted within 6 hours after ischaemic stroke. Serial venous blood samples were taken hourly between 1 to 6 hours, and at 12, 18, 24, 48, 72, 96, and 120 hours after stroke onset. In all patients lesion topography was assessed and infarct volume was calculated. The neurological deficit was quantified by the National Institutes of Health stroke scale score, and functional outcome was assessed with the modified Rankin Scale 3 months after stroke. H-FABP and B-FABP concentrations showed peak values already 2 to 3 hours after stroke onset and remained elevated up to last measurements at 120 hours.Unlike BFABP, early H-FABP concentrations were significantly associated with the severity of the neurological deficit and the functional outcome. High H-FABP release was associated with large infarction on CT. Our study shows for the first time quantitative data of serum BFABP and H-FABP being elevated early in acute ischaemic stroke indicating that especially H-FABP might have the potential to be a rapid marker of brain damage and clinical severity. As both FABPs indicate damage to neuronal and glial tissue but are not specific for cerebral infarction, further investigations are needed to better understand the prolonged release of both in ischaemic stroke which is in contrast to the transient increase after myocardial infarction and can not be explained by their renal extraction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834650     DOI: 10.1007/s00415-005-0725-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

1.  S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.

Authors:  U Missler; M Wiesmann; C Friedrich; M Kaps
Journal:  Stroke       Date:  1997-10       Impact factor: 7.914

2.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

Review 3.  AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart.

Authors:  Nandakumar Sambandam; Gary D Lopaschuk
Journal:  Prog Lipid Res       Date:  2003-05       Impact factor: 16.195

4.  Classification and natural history of clinically identifiable subtypes of cerebral infarction.

Authors:  J Bamford; P Sandercock; M Dennis; J Burn; C Warlow
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

5.  Protein S-100B: a serum marker for ischemic and infectious injury of cerebral tissue.

Authors:  T Bertsch; W Casarin; M Kretschmar; W Zimmer; S Walter; C Sommer; F Muehlhauser; A Ragoschke; S Kuehl; R Schmidt; B P Eden; C Nassabi; T Nichterlein; K Fassbender
Journal:  Clin Chem Lab Med       Date:  2001-04       Impact factor: 3.694

6.  Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke.

Authors:  K Fassbender; R Schmidt; A Schreiner; M Fatar; F Mühlhauser; M Daffertshofer; M Hennerici
Journal:  J Neurol Sci       Date:  1997-05-01       Impact factor: 3.181

7.  Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome.

Authors:  Tomoaki Nakata; Akiyoshi Hashimoto; Mamoru Hase; Kazufumi Tsuchihashi; Kazuaki Shimamoto
Journal:  Cardiology       Date:  2003       Impact factor: 1.869

8.  Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.

Authors:  P Lyden; T Brott; B Tilley; K M Welch; E J Mascha; S Levine; E C Haley; J Grotta; J Marler
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

Review 9.  Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring.

Authors:  Manfred Herrmann; Hannelore Ehrenreich
Journal:  Restor Neurol Neurosci       Date:  2003       Impact factor: 2.406

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  33 in total

1.  H-FABP in the early diagnosis of stroke.

Authors:  Onur Akpinar; Sirma Geyik; Ayça Açikalin; Yeliz Karakan; Ozlem Tiryaki
Journal:  J Neurol       Date:  2009-07-07       Impact factor: 4.849

2.  Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.

Authors:  Markus Britschgi; Kaspar Rufibach; Sarah L Bauer Huang; Christopher M Clark; Jeffrey A Kaye; Ge Li; Elaine R Peskind; Joseph F Quinn; Douglas R Galasko; Tony Wyss-Coray
Journal:  Mol Cell Proteomics       Date:  2011-07-08       Impact factor: 5.911

Review 3.  Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Authors:  Eboni I Lance; James F Casella; Allen D Everett; Emily Barron-Casella
Journal:  Proteomics Clin Appl       Date:  2014-11-06       Impact factor: 3.494

4.  Serum heart-type fatty acid binding protein levels in acromegaly patients.

Authors:  M Ozbek; M Erdogan; M Dogan; E Akbal; M A Ozturk; K Ureten
Journal:  J Endocrinol Invest       Date:  2010-09-09       Impact factor: 4.256

5.  Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis.

Authors:  O Başar; E Akbal; S Köklü; Y Tuna; E Koçak; N Başar; D Tok; H Erbiş; M Senes
Journal:  Herz       Date:  2013-01-18       Impact factor: 1.443

6.  Serum free hemoglobin as a novel potential biomarker for acute ischemic stroke.

Authors:  Poyin Huang; Li-Hua Lo; Yin-Chun Chen; Ruey-Tay Lin; Jentaie Shiea; Ching-Kuan Liu
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

7.  A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage.

Authors:  Natacha Turck; Laszlo Vutskits; Paola Sanchez-Pena; Xavier Robin; Alexandre Hainard; Marianne Gex-Fabry; Catherine Fouda; Hadiji Bassem; Markus Mueller; Frédérique Lisacek; Louis Puybasset; Jean-Charles Sanchez
Journal:  Intensive Care Med       Date:  2009-09-17       Impact factor: 17.440

8.  Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease.

Authors:  Liang-Hao Guo; Panagiotis Alexopoulos; Robert Perneczky
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-04-17       Impact factor: 5.270

9.  Antagonism of P2Y1-induced vasorelaxation by acyl CoA: a critical role for palmitate and 3'-phosphate.

Authors:  E Alefishat; S P H Alexander; V Ralevic
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

10.  Heart-type fatty acid-binding protein: an overlooked cardiac biomarker.

Authors:  Harsh Goel; Joshua Melot; Matthew D Krinock; Ashish Kumar; Sunil K Nadar; Gregory Y H Lip
Journal:  Ann Med       Date:  2020-08-04       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.